BOSULIF cpr pell 100 mg 28 pce
7680622700019
CH-62270
L01EA04
07.16.1.
Reimbursement limitations:
BOSULIF2
Bosulif est indiqué pour le traitement des patients adultes atteints de leucémie myéloïde chronique nouvellement …
1 / 3
google
Details
- Product number
- 6227001
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- bosutinibum 100 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.261 mg, poloxamerum 188, povidonum K 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto.
Articles (1)
Bosulif 100 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.261 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 609.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2014
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 62270
- Drug name
- Bosulif, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/12/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BOSULIF cpr pell 100 mg 28 pce
- Description (DE)
- BOSULIF Filmtabl 100 mg 28 Stk
- Market launch
- 11/12/2013
- Narcotic (BTM)
- No